Archive for November 2020
MBTA proposes cuts to peak-time trains, commuter rail and ferry
The agency outlined other specific changes in the face of a massive budget gap, including ending train service earlier in the night and closing a handful of commuter-rail stations. Read More
Read MoreBoston lands on list of North America’s top 30 tech real estate markets
Boston, according to real estate firm CBRE, ranks No. 14 on the 2020 list, which measures the tech industry’s effects on office markets. Read More
Read MoreModerna stock is getting a boost from Pfizer’s vaccine readout. Here’s why.
Moderna Inc.’s top competitor for developing the first Covid-19 vaccine presented promising late-stage data on its drug Monday morning, but the news was not all bad for Moderna. Read More
Read MoreOne local tech stock surges, two others fall, on vaccine and election news
While stocks across the board saw a massive surge on Monday, at least one Boston-area travel-based tech stock is showing new signs on investor confidence, while shares of two ecommerce retailers who have benefitted from nationwide lockdowns are falling. Read More
Read MoreCollege endowment disclosures highlight growing divide between wealthiest schools and the rest of higher ed
Colleges and universities are digging into their endowments to offset the financial losses brought on by enrollment challenges as well as the broader effects of Covid-19, exacerbating the growing chasm between higher ed’s haves and have-nots. Read More
Read MoreBoston Properties stock jumps after Pfizer vaccine data
Shares of Boston Properties stock shot up 30% Monday morning, as drug giant Pfizer reported a 90% effective rate for its Covid-19 vaccine. Read More
Read MoreBiden names Atul Gawande to Covid-19 task force
Biden’s coronavirus advisory board has multiple members with ties to Massachusetts. Read More
Read MoreTwo Methuen warehouses and 135 acres sold for $64M
The deal comes at a time when industrial real estate in Greater Boston is poised for its biggest year ever. Read More
Read MoreFDA, outside advisers spar over Biogen’s Alzheimer’s drug
An FDA meeting Friday got heated when outside experts debased the positive stance regulators previously took on Biogen Inc.’s Alzheimer’s disease drug. Read More
Read MoreWaiting for ‘better days,’ Tripadvisor bets on subscription model
As international travel continues facing an uncertain near-term future with Covid cases on the rise, Needham-based Tripadvisor Inc. is launching a new subscription-based product seeking to help travelers get better deals for their trips. Read More
Read More